Skip to main content
S

SweetSpot

SweetSpot provides endocrinology practices with a centralized software platform that aggregates continuous glucose monitor (CGM) and insulin pump data from all major devices, enabling clinicians to review and adjust treatment remotely. The service includes virtual diabetes educators who prepare monthly recommendations, communicate changes to patients, and handle follow‑ups, while automatically generating billing reports for the practice. This integrated solution streamlines workflow, improves patient time‑in‑range, and adds revenue without setup or subscription fees.

St Louis, MissouriFounded 2020282K+ followers
Updated 1 month ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Endocrinology practices must collect and interpret data from multiple continuous glucose monitors (CGMs) and insulin pumps, which are hosted on separate manufacturer platforms. This fragmentation creates a time‑consuming workflow, hampers proactive treatment adjustments, and complicates billing for remote diabetes care.

Solution

SweetSpot offers a centralized software platform that aggregates data from all major CGMs and insulin pumps into a single clinician dashboard. The platform enables virtual diabetes educators to review each patient’s monthly glucose trends, generate treatment recommendations, and obtain clinician approval before communicating changes directly to patients. Automated tracking of remote care activities produces billing reports, reducing administrative overhead. By combining data consolidation with wrap‑around clinical support, SweetSpot helps practices deliver proactive diabetes management at scale while simplifying remote‑care documentation.

Target Audience

Primary customers are outpatient endocrinology and diabetes clinics seeking to streamline device data management and expand remote patient monitoring capabilities.

Features

  • Unified dashboard that pulls real‑time data from all leading CGM and insulin pump manufacturers
  • Monthly data review by certified diabetes educators with clinician‑approved treatment recommendations
  • Direct patient communication of approved medication or device adjustments via virtual educators
  • Automated documentation of remote care encounters and generation of billing reports
  • No upfront setup or recurring subscription fees for practices
This profile is AI-generated and may contain inaccuracies.